“Hook Effect” in Calcitonin Immunoradiometric Assay in Patients with Metastatic Medullary Thyroid Carcinoma: Case Report and Review of the Literature | Zendy

Rebecca Lebœuf | Zendy; MarieFrance Langlois | Zendy; Marc Martin | Zendy; Charaf E Ahnadi | Zendy; Guy D. Fink | Zendy

Open Access

“Hook Effect” in Calcitonin Immunoradiometric Assay in Patients with Metastatic Medullary Thyroid Carcinoma: Case Report and Review of the Literature

Author(s) -

Rebecca Lebœuf,

MarieFrance Langlois,

Marc Martin,

Charaf E Ahnadi,

Guy D. Fink

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-1429

Subject(s) - calcitonin , immunoradiometric assay , medicine , thyroid carcinoma , radioimmunoassay , medullary carcinoma , endocrinology , thyroid , pentagastrin , gastroenterology , gastric acid , secretion

Calcitonin is a well-established tumor marker for medullary thyroid carcinoma (MTC). Because surgery is the only effective treatment for patients with MTC, the postoperative level of serum calcitonin will dictate whether residual disease was left behind and whether reintervention is necessary.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research